Jerry Wan Achieve Life Sciences, Inc. (ACHV) insider trading activity

Jerry Wan is Principal Accounting Officer of ACHIEVE LIFE SCIENCES, INC.. Currently has a direct ownership of 32,694 shares of ACHV, which is worth approximately $100,697. The most recent transaction as insider was on Sep 04, 2025, when has been sold 14,070 shares (Common Stock) at a price of $2.77 per share, resulting in proceeds of $38,973. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32.7K

158.16% 3M change

158.16% 12M change

Total Value Held $100,697

Jerry Wan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 04 2025	SELL Open market or private sale	$38,973 $2.77 p/Share	14,070 Reduced 30.09%	32,694 Common Stock
Sep 04 2025	BUY Exercise of conversion of derivative security	-	34,100 Added 42.17%	46,764 Common Stock
Aug 16 2024	BUY Grant, award, or other acquisition	$10,485 $3.67 p/Share	2,857 Added 18.41%	12,664 Common Stock
Apr 19 2024	SELL Payment of exercise price or tax liability	$10,147 $4.51 p/Share	2,250 Reduced 18.66%	9,807 Common Stock
Apr 19 2024	BUY Exercise of conversion of derivative security	-	5,625 Added 31.81%	12,057 Common Stock
Apr 28 2023	SELL Payment of exercise price or tax liability	$5,546 $8.29 p/Share	669 Reduced 9.42%	6,432 Common Stock
Apr 28 2023	BUY Exercise of conversion of derivative security	-	1,250 Added 14.97%	7,101 Common Stock
Apr 21 2023	SELL Payment of exercise price or tax liability	$20,468 $6.8 p/Share	3,010 Reduced 33.97%	5,851 Common Stock
Apr 21 2023	BUY Exercise of conversion of derivative security	-	5,625 Added 38.83%	8,861 Common Stock
Aug 16 2022	SELL Payment of exercise price or tax liability	$1,162 $4.37 p/Share	266 Reduced 7.6%	3,236 Common Stock
Aug 16 2022	BUY Grant, award, or other acquisition	$12,354 $4.37 p/Share	2,827 Added 44.67%	3,502 Common Stock
Apr 28 2022	SELL Payment of exercise price or tax liability	$4,971 $7.43 p/Share	669 Reduced 49.78%	675 Common Stock
Apr 28 2022	BUY Exercise of conversion of derivative security	-	1,250 Added 48.19%	1,344 Common Stock
Aug 17 2021	SELL Payment of exercise price or tax liability	$41 $6.81 p/Share	6 Reduced 6.0%	94 Common Stock
Aug 17 2021	BUY Exercise of conversion of derivative security	-	11 Added 9.91%	100 Common Stock

Jerry Wan

Principal Accounting Officer

Vancouver, A1

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACHV shares.

Notify only if

Value

Insider Trading

Get notified when an Achieve Life Sciences, Inc. insider buys or sells ACHV shares.

Notify only if

Operation

Value

Type

News

Receive news related to ACHIEVE LIFE SCIENCES, INC.

Track Activities on ACHV

Account